Disodium;N-(2-aminophenyl)-4-[4-[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-yl]oxan-4-yl]benzamide;N-(2-aminophenyl)-4-[4-(4-pyridin-3-yl-1,3-thiazol-2-yl)oxan-4-yl]benzamide;bis(benzene-1,2-diamine);1-bromo-2-(2-bromoethoxy)ethane;2-bromo-1-(2-methylimidazo[1,2-a]pyridin-3-yl)ethanone;2-bromo-1-pyridin-3-ylethanone;hydroxyazanide;methanol;methyl 4-(4-carbamothioyloxan-4-yl)benzoate;4-[4-[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-yl]oxan-4-yl]benzoic acid;methyl 4-(isocyanomethyl)benzoate;methyl 4-(4-isocyanooxan-4-yl)benzoate;methyl 4-[4-[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-yl]oxan-4-yl]benzoate;methyl 4-[4-(4-pyridin-3-yl-1,3-thiazol-2-yl)oxan-4-yl]benzoate;oxolane;4-[4-(4-pyridin-3-yl-1,3-thiazol-2-yl)oxan-4-yl]benzoic acid
C223H245Br4N31Na2O35S7 — CID 157475413
Data last refreshed: (MolForge compound catalog, from PubChem)
About Disodium;N-(2-aminophenyl)-4-[4-[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-yl]oxan-4-yl]benzamide;N-(2-aminophenyl)-4-[4-(4-pyridin-3-yl-1,3-thiazol-2-yl)oxan-4-yl]benzamide;bis(benzene-1,2-diamine);1-bromo-2-(2-bromoethoxy)ethane;2-bromo-1-(2-methylimidazo[1,2-a]pyridin-3-yl)ethanone;2-bromo-1-pyridin-3-ylethanone;hydroxyazanide;methanol;methyl 4-(4-carbamothioyloxan-4-yl)benzoate;4-[4-[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-yl]oxan-4-yl]benzoic acid;methyl 4-(isocyanomethyl)benzoate;methyl 4-(4-isocyanooxan-4-yl)benzoate;methyl 4-[4-[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-yl]oxan-4-yl]benzoate;methyl 4-[4-(4-pyridin-3-yl-1,3-thiazol-2-yl)oxan-4-yl]benzoate;oxolane;4-[4-(4-pyridin-3-yl-1,3-thiazol-2-yl)oxan-4-yl]benzoic acid
Disodium;N-(2-aminophenyl)-4-[4-[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-yl]oxan-4-yl]benzamide;N-(2-aminophenyl)-4-[4-(4-pyridin-3-yl-1,3-thiazol-2-yl)oxan-4-yl]benzamide;bis(benzene-1,2-diamine);1-bromo-2-(2-bromoethoxy)ethane;2-bromo-1-(2-methylimidazo[1,2-a]pyridin-3-yl)ethanone;2-bromo-1-pyridin-3-ylethanone;hydroxyazanide;methanol;methyl 4-(4-carbamothioyloxan-4-yl)benzoate;4-[4-[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-yl]oxan-4-yl]benzoic acid;methyl 4-(isocyanomethyl)benzoate;methyl 4-(4-isocyanooxan-4-yl)benzoate;methyl 4-[4-[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-yl]oxan-4-yl]benzoate;methyl 4-[4-(4-pyridin-3-yl-1,3-thiazol-2-yl)oxan-4-yl]benzoate;oxolane;4-[4-(4-pyridin-3-yl-1,3-thiazol-2-yl)oxan-4-yl]benzoic acid (PubChem CID 157475413) has the molecular formula C223H245Br4N31Na2O35S7 and a molecular weight of 4509.66 g/mol. Its IUPAC name is disodium;N-(2-aminophenyl)-4-[4-[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-yl]oxan-4-yl]benzamide;N-(2-aminophenyl)-4-[4-(4-pyridin-3-yl-1,3-thiazol-2-yl)oxan-4-yl]benzamide;bis(benzene-1,2-diamine);1-bromo-2-(2-bromoethoxy)ethane;2-bromo-1-(2-methylimidazo[1,2-a]pyridin-3-yl)ethanone;2-bromo-1-pyridin-3-ylethanone;hydroxyazanide;methanol;methyl 4-(4-carbamothioyloxan-4-yl)benzoate;4-[4-[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-yl]oxan-4-yl]benzoic acid;methyl 4-(isocyanomethyl)benzoate;methyl 4-(4-isocyanooxan-4-yl)benzoate;methyl 4-[4-[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-yl]oxan-4-yl]benzoate;methyl 4-[4-(4-pyridin-3-yl-1,3-thiazol-2-yl)oxan-4-yl]benzoate;oxolane;4-[4-(4-pyridin-3-yl-1,3-thiazol-2-yl)oxan-4-yl]benzoic acid.
Molecular Properties
| Compound Name | Disodium;N-(2-aminophenyl)-4-[4-[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-yl]oxan-4-yl]benzamide;N-(2-aminophenyl)-4-[4-(4-pyridin-3-yl-1,3-thiazol-2-yl)oxan-4-yl]benzamide;bis(benzene-1,2-diamine);1-bromo-2-(2-bromoethoxy)ethane;2-bromo-1-(2-methylimidazo[1,2-a]pyridin-3-yl)ethanone;2-bromo-1-pyridin-3-ylethanone;hydroxyazanide;methanol;methyl 4-(4-carbamothioyloxan-4-yl)benzoate;4-[4-[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-yl]oxan-4-yl]benzoic acid;methyl 4-(isocyanomethyl)benzoate;methyl 4-(4-isocyanooxan-4-yl)benzoate;methyl 4-[4-[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-yl]oxan-4-yl]benzoate;methyl 4-[4-(4-pyridin-3-yl-1,3-thiazol-2-yl)oxan-4-yl]benzoate;oxolane;4-[4-(4-pyridin-3-yl-1,3-thiazol-2-yl)oxan-4-yl]benzoic acid |
|---|---|
| PubChem CID | 157475413 |
| Molecular Formula | C223H245Br4N31Na2O35S7 |
| Molecular Weight | 4509.66 g/mol |
| Exact Mass | 4502.29 |
| IUPAC Name | disodium;N-(2-aminophenyl)-4-[4-[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-yl]oxan-4-yl]benzamide;N-(2-aminophenyl)-4-[4-(4-pyridin-3-yl-1,3-thiazol-2-yl)oxan-4-yl]benzamide;bis(benzene-1,2-diamine);1-bromo-2-(2-bromoethoxy)ethane;2-bromo-1-(2-methylimidazo[1,2-a]pyridin-3-yl)ethanone;2-bromo-1-pyridin-3-ylethanone;hydroxyazanide;methanol;methyl 4-(4-carbamothioyloxan-4-yl)benzoate;4-[4-[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-yl]oxan-4-yl]benzoic acid;methyl 4-(isocyanomethyl)benzoate;methyl 4-(4-isocyanooxan-4-yl)benzoate;methyl 4-[4-[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-yl]oxan-4-yl]benzoate;methyl 4-[4-(4-pyridin-3-yl-1,3-thiazol-2-yl)oxan-4-yl]benzoate;oxolane;4-[4-(4-pyridin-3-yl-1,3-thiazol-2-yl)oxan-4-yl]benzoic acid |
| SMILES | BrCCOCCBr.C1CCOC1.CO.CO.CO.CO.CO.COC(=O)c1ccc(C2(C(N)=S)CCOCC2)cc1.COC(=O)c1ccc(C2(c3nc(-c4c(C)nc5ccccn45)cs3)CCOCC2)cc1.COC(=O)c1ccc(C2(c3nc(-c4cccnc4)cs3)CCOCC2)cc1.Cc1nc2ccccn2c1-c1csc(C2(c3ccc(C(=O)Nc4ccccc4N)cc3)CCOCC2)n1.Cc1nc2ccccn2c1-c1csc(C2(c3ccc(C(=O)O)cc3)CCOCC2)n1.Cc1nc2ccccn2c1C(=O)CBr.Nc1ccccc1N.Nc1ccccc1N.Nc1ccccc1NC(=O)c1ccc(C2(c3nc(-c4cccnc4)cs3)CCOCC2)cc1.O=C(CBr)c1cccnc1.O=C(O)c1ccc(C2(c3nc(-c4cccnc4)cs3)CCOCC2)cc1.[C-]#[N+]C1(c2ccc(C(=O)OC)cc2)CCOCC1.[C-]#[N+]Cc1ccc(C(=O)OC)cc1.[NH-]O.[NH-]O.[Na+].[Na+] |
| InChI | InChI=1S/C29H27N5O2S.C26H24N4O2S.C24H23N3O3S.C23H21N3O3S.C21H20N2O3S.C20H18N2O3S.C14H17NO3S.C14H15NO3.C10H9BrN2O.C10H9NO2.C7H6BrNO.2C6H8N2.C4H8Br2O.C4H8O.5CH4O.2H2NO.2Na/c1-19-26(34-15-5-4-8-25(34)31-19)24-18-37-28(33-24)29(13-16-36-17-14-29)21-11-9-20(10-12-21)27(35)32-23-7-3-2-6-22(23)30;27-21-5-1-2-6-22(21)29-24(31)18-7-9-20(10-8-18)26(11-14-32-15-12-26)25-30-23(17-33-25)19-4-3-13-28-16-19;1-16-21(27-12-4-3-5-20(27)25-16)19-15-31-23(26-19)24(10-13-30-14-11-24)18-8-6-17(7-9-18)22(28)29-2;1-15-20(26-11-3-2-4-19(26)24-15)18-14-30-22(25-18)23(9-12-29-13-10-23)17-7-5-16(6-8-17)21(27)28;1-25-19(24)15-4-6-17(7-5-15)21(8-11-26-12-9-21)20-23-18(14-27-20)16-3-2-10-22-13-16;23-18(24)14-3-5-16(6-4-14)20(7-10-25-11-8-20)19-22-17(13-26-19)15-2-1-9-21-12-15;1-17-12(16)10-2-4-11(5-3-10)14(13(15)19)6-8-18-9-7-14;1-15-14(7-9-18-10-8-14)12-5-3-11(4-6-12)13(16)17-2;1-7-10(8(14)6-11)13-5-3-2-4-9(13)12-7;1-11-7-8-3-5-9(6-4-8)10(12)13-2;8-4-7(10)6-2-1-3-9-5-6;2*7-5-3-1-2-4-6(5)8;5-1-3-7-4-2-6;1-2-4-5-3-1;7*1-2;;/h2-12,15,18H,13-14,16-17,30H2,1H3,(H,32,35);1-10,13,16-17H,11-12,14-15,27H2,(H,29,31);3-9,12,15H,10-11,13-14H2,1-2H3;2-8,11,14H,9-10,12-13H2,1H3,(H,27,28);2-7,10,13-14H,8-9,11-12H2,1H3;1-6,9,12-13H,7-8,10-11H2,(H,23,24);2-5H,6-9H2,1H3,(H2,15,19);3-6H,7-10H2,2H3;2-5H,6H2,1H3;3-6H,7H2,2H3;1-3,5H,4H2;2*1-4H,7-8H2;1-4H2;1-4H2;5*2H,1H3;2*1-2H;;/q;;;;;;;;;;;;;;;;;;;;2*-1;2*+1 |
| InChIKey | BVNIZIDPERLFFA-UHFFFAOYSA-N |
| XLogP | 35.31 |
| TPSA | 968.91 Ų |
| H-Bond Donors | 18 |
| H-Bond Acceptors | 64 |
| Rotatable Bonds | 41 |
| Heavy Atoms | 302 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 4509.66 |
| LogP ≤ 5 | 35.31 |
| H-Bond Donors ≤ 5 | 18 |
| H-Bond Acceptors ≤ 10 | 64 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157475413 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.